The world's largest producer of health products, Johnson & Johnson, reported an increase in net profit in the third quarter by 4.6% in annual terms to 3 billion 934 million dollars. Adjusted earnings were 2 dollars 5 cents per share, while experts had predicted 2 dollars 3 cents per share. Revenues reached $20 billion 300 million, exceeding economists' estimates of $20 billion 100 million. The pharmaceutical division increased quarterly sales by 6.7%. Growth in sales of consumer goods was 1.8%. Sales of medical devices rose 0.2%.
American Airlines will cut 30% of its workforce including management and support staff27.05.2020
National Bank of Canada, Scotiabank surpass forecast despite profit decline19.05.2020
J.C. Penney plans to permanently close its 242 stores amid bankruptcy12.05.2020
Japan to approve its first coronavirus antigen test kits on Wednesday